On the Front Lines: Managing CRS in the Emergency Department

Presented by: Johns Hopkins School University of Medicine

Release Date: April 23, 2025                                                                      

Expiration Date: April 23, 2026

Estimated time to complete this activity: 4.25 hours. This activity has been approved for a maximum of 4.25 AMA PRA Category 1 Credits™.

Fees and Prerequisites: There are no fees or prerequisites.

Acknowledgement of Commercial Support: Supported by educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and Novartis Pharmaceuticals Corporation.

Target Audience

This activity is intended to meet the educational needs of emergency department clinicians.

Learning Objectives

 After participating in this activity, learners will demonstrate the ability to:

• Identify the common adverse events seen with bispecific antibodies and CAR T therapies that would present in the emergency department setting.
• Apply guideline recommendations and expert opinion to the identification of bispecific antibody and CAR T-cell therapy-related CRS in the emergency setting.
• Use practical approaches to CRS management in patients receiving bispecific antibodies and CAR T-cell therapies and establish open communication pathways with oncology experts.

Presented by the Johns Hopkins University School of Medicine

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Johns Hopkins University School of Medicine and Medical Logix, LLC. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement 

The Johns Hopkins University School of Medicine designates this Other activity (Blended Learning with Digital Modules and Live Sessions) for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit^TM from organizations accredited by the ACCME.

American Association of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of PAs (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. PAs may receive a maximum of 4.25 AAPA Category 1 Credit for completing this program.

American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) Program

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.25 MOC points for Medical Knowledge + Practice Assessment in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Policy on Presenter and Provider DisclosureIt is the policy of the Johns Hopkins University School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

Statement of Need

Rigorous clinical research has led to the discovery of novel immunologic therapies. Chimeric antigen receptor T cell (CAR T-cell) therapy has shown impressive outcomes but is associated with a significant risk of adverse events (AEs), chiefly cytokine release syndrome (CRS). Bispecific antibodies act through a similar mechanism of action but offer a lower risk of CRS. These AEs may require immediate management, which may occur in the emergency department (ED) setting. 

Given the novelty and specialty nature of bispecific antibody and CAR T-cell therapies, ED clinicians face several challenges in the practical management of patients receiving these therapies. Similarly, given the breadth of conditions treated with these therapies, ED clinicians may face difficulties knowing which patient populations are at risk. While CAR T therapies are approved for hematologic malignancies, bispecific antibodies are approved for many indications including hematologic malignancies, non-small cell lung cancer, uveal melanoma, hemophilia A, and neovascular macular edema. This collaborative social learning platform establishes a network of providers who can create a sustainable network of providers who can continue to support each other following this experience in implementing their practice action plans aimed at improving the care provided to patients on CAR T or bispecific therapies.

Format and Method of Participation

Review this web-video session CME activity. To take the post-test, please click on the post-test button below the video window of the player which will take you to the Johns Hopkins School of Medicine’s website. If you already have registered for other programs at this website, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. The information you enter here will be used to generate your CME certificate. Please complete all fields to ensure accurate registration. Complete the post-test and evaluation and attest to the amount of time spent in the activity. Upon receiving a score of 70% or above, print your CME certificate.

Full Disclosure Policy Affecting CME Activities

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with ineligible companies from any individual in a position to control the content of a CME activity sponsored by OCME.

Faculty

Syed Abbas Ali, MBBS – Consulting Fee: Aduro Biotec, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Curio Science, Janssen, Oncopeptides, Sanofi, Takeda; Grant or research support: Aduro Biotec, Bristol-Myers Squibb, Celgene, Pfizer, Inc., Poseida

Nazila Shafagati – No relevant relationships with ineligible companies to disclose

No one else in a position to control the content of this educational activity has disclosed a relevant financial interest or relationship with an ineligible company. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Johns Hopkins Statement of Responsibility

The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Copyright

All rights reserved - The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

Internet CME Policy

The Office of Continuing Medical Education (OCME) at the Johns Hopkins School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins School of Medicine OCME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. OCME at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine CME program. CME collects only the information necessary to provide you with the services that you request. 

Disclaimer

The opinions and recommendations expressed by faculty and other experts, whose input is included in this program are their own. This other activity/ live webinar and self-study digital modules are produced for educational purposes only. Use of the Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

AMERICANS WITH DISABILITIES ACT

The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

Course Format – Method of Participation

This web-video session is expected to take approximately 4.25 hours to complete. Once the activity is completed, you must pass the post-test and complete the evaluation with attestation to receive CME credit. To receive the maximum amount of credit available, you must complete all of the following:

• Baseline and Final Self-Assessments: 0.5 credit each for a total of 1.0 hour of CME credit
• Three self-study modules: 0.75 CME credit
• One live group session: 1.5 hours of CME credit
• One Group Challenge and the Action Plan: 0.50 credit each for a total of 1.0 hours of CME credit

Faculty

Syed Abbas Ali, MBBS
Assistant Professor of Oncology
Department of Oncology, Hematologic Malignancies
Johns Hopkins School of Medicine
Baltimore, MD

Nazila Shafagati, MD
Medical Oncology Fellow
Johns Hopkins School of Medicine
Baltimore, MD

What you should know about gifts to physicians from industry

Gift giving from the pharmaceutical, device and medical equipment industries to physicians has long been a customary practice. But when gift giving is not practiced within established ethical boundaries, the perception of conflict of interest is raised. All physicians and physicians in training should adhere to the AMA Code of Medical Ethics, Opinion 8.061, “Gifts to Physicians from Industry” which can be found under the AMA Code of Medical Ethics at https://code-medical-ethics.ama-assn.org/ethics-opinions/gifts-physicians-industry.

Johns Hopkins faculty, staff, employees, students, and trainees must adhere to the more restrictive Johns Hopkins Medicine Policy on Interaction with Industry that can be found at this link https://industryinteraction.jhu.edu/jhm-policy-on-interaction-with-industry.

Off-Label Discussion

There are no references to off-label/unapproved uses of products in this program.

Confidentiality Disclaimer for CME Activity Participant

I certify that I am participating in this Johns Hopkins School of Medicine activity for CME-accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the “Privacy Regulations”). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g., Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is:  Johns Hopkins Privacy Officer, telephone: 410-614-9900 ,

e-mail: HIPAA@jhmi.edu.

“The Office of Continuing Medical Education at the Johns Hopkins School of Medicine, as sponsor of this activity, has relayed information with the CME attendees/participants and certify that the visitor is here for training, education and/or observation purposes only.”

For CME questions, please contact the CME Office 410-955-2959 or email cmenet@jhmi.edu.

For CME Certificates, please call (410) 502-9636.

Johns Hopkins School of Medicine
Office of Continuing Medical Education
720 Rutland Avenue/ Turner 20
Baltimore, Maryland 21205-2195
Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)